Ravi Chari

Ravi Chari has over 40 years of experience in biotechnology and chemistry. Ravi began their career in 1980 as a Yale-Celanese Post Doctoral Fellow at Yale University School of Medicine's Department of Pharmacology. In 1986, they moved to the Dana-Farber Cancer Institute as a Research Scientist. In 1988, they joined ImmunoGen, Inc. as Director of Chemistry, later becoming Executive Director of Chemistry & Biochemistry and then Vice President of Chemistry & Biochemistry. In 2019, they founded RChari Consulting, where they serve as a Biotechnology Consultant, leveraging their experience in all aspects of Antibody-Drug Conjugates (ADCs). In 2021, they joined Full-Life Technologies as Chief Scientific Officer.

Ravi Chari completed their Ph.D. in Chemistry from Detroit in 1980, after studying there from 1975.